Amyloid-beta clearance in Alzheimer's disease

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Frontiers Research Topics
Main Authors: Robert Marr, Eliezer Masliah
Formato: Livro
Idioma:Inglês
Publicado: Frontiers Media SA 2015
Assuntos:
RC321-571
Q1-390
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
amyloid-beta
Signal Transduction
Proteases
LDL receptors
Clearance
Alzheimer's disease
Acceso en liña:https://directory.doabooks.org/handle/20.500.12854/40785
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares